Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Indomethacin: Can It Counteract Bradykinin Effects in COVID-19 Patients?
Myasar Alkotaji, Radhwan Nidal Al-Zidan
Current Pharmacology Reports (2021) Vol. 7, Iss. 3, pp. 102-106
Open Access | Times Cited: 18

Showing 18 citing articles:

Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents
Norberto Perico, Monica Cortinovis, Fredy Suter, et al.
The Lancet Infectious Diseases (2022) Vol. 23, Iss. 1, pp. e22-e33
Open Access | Times Cited: 67
An open label randomized clinical trial of Indomethacin for mild and moderate hospitalised Covid-19 patients
Rajan Ravichandran, Krishna Mohan Surapaneni, Suresh Kumar Sukumaran, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 33
Protein structure-based in-silico approaches to drug discovery: Guide to COVID-19 therapeutics
Yash Gupta, Oleksandr V. Savytskyi, Matt Coban, et al.
Molecular Aspects of Medicine (2022) Vol. 91, pp. 101151-101151
Open Access | Times Cited: 30
Indomethacin for refractory COVID or post-COVID headache: a retrospective study
Abouch Valenty Krymchantowski, Raimundo Pereira Silva‐Néto, Carla Jevoux, et al.
Acta Neurologica Belgica (2021) Vol. 122, Iss. 2, pp. 465-469
Open Access | Times Cited: 39
A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Management of Mild-to-Moderate Symptomatic COVID-19
Sergio Fazio, Flora Affuso, Paolo Bellavite
Medical Science Monitor (2022) Vol. 28
Open Access | Times Cited: 17
In-silico screening and in-vitro assay show the antiviral effect of Indomethacin against SARS-CoV-2
Rajkumar Chakraborty, Gourab Bhattacharje, Joydeep Baral, et al.
Computers in Biology and Medicine (2022) Vol. 147, pp. 105788-105788
Open Access | Times Cited: 15
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis of Early COVID-19 and Treated at Home Within 3 Days or After 3 Days of Symptom Onset with Prescribed and Non-Prescribed Treatments Between November 2020 and August 2021
Sergio Fazio, Paolo Bellavite, Elisabetta Zanolin, et al.
Medical Science Monitor (2021) Vol. 28
Open Access | Times Cited: 19
Early Multi-Target Treatment of Mild-to-Moderate COVID-19, Particularly in Terms of Non-Steroidal Anti-Inflammatory Drugs and Indomethacin
Sergio Fazio, Paolo Bellavite
BioMed (2023) Vol. 3, Iss. 1, pp. 177-194
Open Access | Times Cited: 5
Home pharmacological therapy in early COVID‐19 to prevent hospitalization and reduce mortality: Time for a suitable proposal
Sergio Pandolfi, Salvatore Chirumbolo, Giovanni Ricevuti, et al.
Basic & Clinical Pharmacology & Toxicology (2021) Vol. 130, Iss. 2, pp. 225-239
Open Access | Times Cited: 11
Роль брадикініну в розвитку COVID-19 та інших захворювань
V.M. Pushkarev, О.І. Ковзун, Н.І. Левчук, et al.
Endokrynologia (2023) Vol. 28, Iss. 4, pp. 349-362
Open Access | Times Cited: 3
An Updated Review on Complicated Mechanisms of COVID-19 Pathogenesis and Therapy: Direct Viral Damage, Renin-angiotensin System Dysregulation, Immune System Derangements, and Endothelial Dysfunction
Shahab Falahi, Maryam Maleki, Azra Kenarkoohi
Infectious Disorders - Drug Targets (2022) Vol. 22, Iss. 7
Closed Access | Times Cited: 5
Evaluation of noscapine-licorice combination effects on cough relieving in COVID-19 outpatients: A randomized controlled trial
Saghar Barati, Faezeh Feizabadi, Hakimeh Khalaj, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 2
Are some COVID-19 vaccines better than others regarding the short-term side effects?
Radhwan Nidal Al-Zidan, Omeed Darweesh, Muhanad Salah, et al.
Česká a slovenská farmacie (2023) Vol. 72, Iss. 1, pp. 45-54
Closed Access | Times Cited: 2
Therapeutic Approaches in COVID-19 Patients: The Role of the Renin-Angiotensin System
Farzaneh Ketabchi, Sina Jamzad
Canadian Respiratory Journal (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 2
Indomethacin Use for Mild & Moderate hospitalised Covid-19 patients: An open label randomized clinical trial
Rajan Ravichandran, Krishna Mohan Surapaneni, Suresh Kumar Sukumaran, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 2
A survival analysis of socio-demographic and clinical predictors among hospitalized COVID-19 patients in Southern Iran
Atefeh Esfandiari, Jamileh Kiani, Batool Amiri, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access
Selection an Effective Drug Regimen on the Tumor Microenvironment of Non-invasive to Invasive Human Retinoblastoma
Saeedeh TarvijEslami, Hosain Nasirian, Alimohamad Nasirian, et al.
Research Square (Research Square) (2023)
Open Access
A Survival Analysis of Socio-Demographic and Clinical Predictors Among Hospitalized COVID-19 Patients in Southern Iran
Atefeh Esfandiari, Jamileh Kiani, Batool Amiri, et al.
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top